251 related articles for article (PubMed ID: 25944686)
1. Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.
Albano F; Zagaria A; Anelli L; Coccaro N; Tota G; Brunetti C; Minervini CF; Impera L; Minervini A; Cellamare A; Orsini P; Cumbo C; Casieri P; Specchia G
Oncotarget; 2015 May; 6(15):13269-77. PubMed ID: 25944686
[TBL] [Abstract][Full Text] [Related]
2. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
Lang L; Li HM; Liu H; Wang YM; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
[TBL] [Abstract][Full Text] [Related]
3. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
[TBL] [Abstract][Full Text] [Related]
5. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
[TBL] [Abstract][Full Text] [Related]
6. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.
Sueki A; Matsuda K; Taira C; Yamaguchi A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
Clin Chim Acta; 2013 Jan; 415():276-8. PubMed ID: 23159843
[TBL] [Abstract][Full Text] [Related]
8. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
Zhu HH; Qin YZ; Lai YY; Shi HX; Liu YR; Jiang B; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):872-8. PubMed ID: 23998577
[TBL] [Abstract][Full Text] [Related]
9. No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
Rasekh EO; Elsayed GM; Fathy S
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
Nasilowska-Adamska B; Majewski M; Seferynska I; Szczepinski A; Tomaszewska A; Prochorec-Sobieszek M; Guz K; Torbicki A; Warzocha K; Marianska B
Ann Transplant; 2007; 12(3):33-8. PubMed ID: 18290568
[TBL] [Abstract][Full Text] [Related]
11. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
[TBL] [Abstract][Full Text] [Related]
12. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract][Full Text] [Related]
13. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G
Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420
[TBL] [Abstract][Full Text] [Related]
14. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
Diverio D; Rossi V; Avvisati G; De Santis S; Pistilli A; Pane F; Saglio G; Martinelli G; Petti MC; Santoro A; Pelicci PG; Mandelli F; Biondi A; Lo Coco F
Blood; 1998 Aug; 92(3):784-9. PubMed ID: 9680345
[TBL] [Abstract][Full Text] [Related]
15. Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
Iaccarino L; Divona M; Ottone T; Cicconi L; Lavorgna S; Ciardi C; Alfonso V; Travaglini S; Facchini L; Cimino G; Di Bona E; Voso MT; Lo-Coco F
Genes Chromosomes Cancer; 2019 Jan; 58(1):60-65. PubMed ID: 30421475
[TBL] [Abstract][Full Text] [Related]
16. Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.
Walz C; Grimwade D; Saussele S; Lengfelder E; Haferlach C; Schnittger S; Lafage-Pochitaloff M; Hochhaus A; Cross NC; Reiter A
Genes Chromosomes Cancer; 2010 May; 49(5):471-9. PubMed ID: 20155840
[TBL] [Abstract][Full Text] [Related]
17. High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study.
Yoon JH; Kim HJ; Kwak DH; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
J Hematol Oncol; 2017 Jan; 10(1):30. PubMed ID: 28114959
[TBL] [Abstract][Full Text] [Related]
18. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH.
Han JY; Kim KE; Kim KH; Park JI; Kim JS
Leuk Res; 2007 Feb; 31(2):239-43. PubMed ID: 16797070
[TBL] [Abstract][Full Text] [Related]
19. An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3.
Cao Y; Yao L; Liu Y; Gu Q; Dong W; Wang Z; Wang F; Lin R; Xie X; Cen J; Chen S; Gu W
Acta Haematol; 2019; 142(2):98-104. PubMed ID: 31085908
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
